II. Indications
- Inhaled Corticosteroids are the most important agent in Asthma Management
- Indicated as daily maintenance agents in all persistent Asthma
III. Background
IV. Dosing: Beclomethasone Dipropionate HFA MDI (QVAR RediHaler)
- Use child dosing for age 6 to 11 years old
- Low dose
- Medium dose
- High dose
V. Adverse Effects
VI. Efficacy
VII. Safety
- Pregnancy Category C
- Unknown Safety in Lactation
VIII. Resources
- Beclomethasone Dipropionate HFA MDI or QVAR RediHaler (DailyMed)
Images: Related links to external sites (from Bing)
Related Studies
qvar (on 8/17/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
QVAR REDIHALER 40 MCG | $18.09 per gram | |
QVAR REDIHALER 80 MCG | $24.25 per gram |
Ontology: Respiratory beclomethasone (C0358521)
Concepts | Clinical Drug (T200) |
SnomedCT | 349368005 |
English | Respiratory beclomethasone, Respiratory beclomethasone (product), Respiratory beclomethasone (substance) |
Spanish | beclometasona de uso respiratorio (producto), beclometasona de uso respiratorio |
Ontology: Beclovent (C0699071)
Concepts | Pharmacologic Substance (T121) , Steroid (T110) |
MSH | D001507 |
English | Beclovent, GlaxoSmithKline Brand 3 of Beclomethasone Dipropionate |
Ontology: Vanceril (C0699073)
Concepts | Pharmacologic Substance (T121) , Steroid (T110) |
MSH | D001507 |
English | vanceril, Vanceril, Schering Brand 2 of Beclomethasone Dipropionate |